Catherine François

2.2k total citations · 1 hit paper
62 papers, 1.6k citations indexed

About

Catherine François is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Catherine François has authored 62 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hepatology, 26 papers in Epidemiology and 23 papers in Infectious Diseases. Recurrent topics in Catherine François's work include Hepatitis C virus research (33 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (10 papers). Catherine François is often cited by papers focused on Hepatitis C virus research (33 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (10 papers). Catherine François collaborates with scholars based in France, Belgium and Lebanon. Catherine François's co-authors include Sandrine Castelain, Gilles Duverlie, Étienne Brochot, François Helle, Virginie Morel, Véronique Descamps, Christophe Louandre, Antoine Galmiche, Corinne Godin and Zuzana Saidak and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Virology.

In The Last Decade

Catherine François

61 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells

2014 315 citations Christophe Louandre, Ingrid Marcq et al. Cancer Letters profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine François France	23	541	478	464	435	313	62	1.6k
Paola Del Porto Italy	24	230 0.4×	510 1.1×	400 0.9×	105 0.2×	284 0.9×	53	1.5k
René Gerolami France	30	2.1k 3.8×	827 1.7×	446 1.0×	986 2.3×	121 0.4×	102	3.0k
Chikako Ono Japan	20	320 0.6×	358 0.7×	677 1.5×	476 1.1×	42 0.1×	68	1.6k
Jin‐Hwan Han United States	14	618 1.1×	676 1.4×	236 0.5×	76 0.2×	83 0.3×	27	1.7k
Keiji Ueda Japan	30	1.1k 2.0×	1.7k 3.6×	576 1.2×	320 0.7×	76 0.2×	151	2.9k
Isabel Fofana France	18	975 1.8×	755 1.6×	587 1.3×	282 0.6×	42 0.1×	26	1.9k
Catherine Schuster France	30	1.6k 2.9×	1.3k 2.8×	755 1.6×	198 0.5×	50 0.2×	82	2.7k
Xianfang Wu United States	20	642 1.2×	551 1.2×	972 2.1×	390 0.9×	41 0.1×	37	2.2k
Benjamin Israelow United States	13	257 0.5×	320 0.7×	585 1.3×	556 1.3×	62 0.2×	15	1.5k
Zhengkun Tu China	23	872 1.6×	839 1.8×	225 0.5×	181 0.4×	44 0.1×	44	1.9k

Countries citing papers authored by Catherine François

Since Specialization

Citations

This map shows the geographic impact of Catherine François's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine François with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine François more than expected).

Fields of papers citing papers by Catherine François

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine François. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine François. The network helps show where Catherine François may publish in the future.

Co-authorship network of co-authors of Catherine François

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine François. A scholar is included among the top collaborators of Catherine François based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine François. Catherine François is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

François, Catherine, et al.. (2025). Evolution of Epstein–Barr Virus Infection Seroprevalence in a French University Hospital over 11 Years, Including the COVID-19 Pandemic, 2013–2023. Microorganisms. 13(4). 733–733.

Lebon, Delphine, Alexis Caulier, Magalie Joris, et al.. (2022). Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease. Leukemia Research. 125. 107005–107005. 3 indexed citations

Touzé, Antoine, Fadi Abdel‐Sater, Virginie Morel, et al.. (2021). Impact of pre-graft serology on risk of BKPyV infection post-renal transplantation. Nephrology Dialysis Transplantation. 37(4). 781–788. 8 indexed citations

Louandre, Christophe, Corinne Godin, Virginie Morel, et al.. (2020). SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma. Biochemical and Biophysical Research Communications. 533(4). 1083–1087. 32 indexed citations

Brochot, Étienne, Baptiste Demey, Antoine Touzé, et al.. (2020). Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals. Frontiers in Microbiology. 11. 584251–584251. 98 indexed citations

Demey, Baptiste, Sandra Bodeau, Catherine François, et al.. (2019). Analytical performance evaluation and enhancement of the ADVIA Centaur® HIV Ag/Ab Combo assay. Journal of Clinical Virology. 118. 36–40. 3 indexed citations

Oliveira, Catarina, Carole Fournier, V Descamps, et al.. (2017). Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles. Hepatology. 65(6). 1851–1864. 12 indexed citations

Morel, Virginie, Catarina Oliveira, Catherine François, et al.. (2015). Phylogenetic analysis of a circulating hepatitis C virus recombinant strain 1b/1a isolated in a French hospital centre. Infection Genetics and Evolution. 40. 374–380. 5 indexed citations

Dufresne, M., François Helle, Thomas Hoffmann, et al.. (2014). Alginate Hydrogel Protects Encapsulated Hepatic HuH-7 Cells against Hepatitis C Virus and Other Viral Infections. PLoS ONE. 9(10). e109969–e109969. 29 indexed citations

10.

Castelain, Sandrine, et al.. (2014). Simeprevir for the treatment of hepatitis C virus infection. Pharmacogenomics and Personalized Medicine. 7. 241–241. 42 indexed citations

11.

Brochot, Étienne, François Helle, Catherine François, et al.. (2014). Which therapeutic option for hepatitis C virus genotype 1?. Scandinavian Journal of Gastroenterology. 50(4). 470–478. 3 indexed citations

12.

Louandre, Christophe, Ingrid Marcq, Hicham Bouhlal, et al.. (2014). The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells. Cancer Letters. 356(2). 971–977. 315 indexed citations breakdown →

13.

Bodeau, Sandra, Anne‐Sophie Lemaire‐Hurtel, Catherine François, et al.. (2013). The End-of-Treatment Ribavirin Concentration Predicts Hepatitis C Virus Relapse. Therapeutic Drug Monitoring. 35(6). 791–795. 6 indexed citations

14.

Galmiche, Antoine, Zakaria Ezzoukhry, Catherine François, et al.. (2010). BAD, a Proapoptotic Member of the BCL2 Family, Is a Potential Therapeutic Target in Hepatocellular Carcinoma. Molecular Cancer Research. 8(8). 1116–1125. 43 indexed citations

15.

Nguyen-Khac, Éric, Dominique Capron, Sandrine Castelain, Catherine François, & Alain Braillon. (2007). Personalized therapy for chronic viral hepatitis C in the naive patient: How can we optimize treatment duration as a function of viral genotype?. European Journal of Internal Medicine. 18(7). 510–515. 4 indexed citations

16.

Castelain, Sandrine, François Pénin, Catherine François, et al.. (2006). Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadine. Journal of Medical Virology. 79(2). 144–154. 17 indexed citations

17.

Castelain, Sandrine, Véronique Descamps, Vincent Thibault, et al.. (2004). TaqMan amplification system with an internal positive control for HCV RNA quantitation. Journal of Clinical Virology. 31(3). 227–234. 67 indexed citations

18.

Castelain, Sandrine, Catherine François, Dorine Bonte, et al.. (2004). Epidemiological and quantitative study of GBV‐C infection in french polytransfused children. Journal of Medical Virology. 73(4). 596–600. 9 indexed citations

19.

Castelain, Sandrine, Hafida Khorsi, Catherine François, et al.. (2002). Variability of the Nonstructural 5A Protein of Hepatitis C Virus Type 3a Isolates and Relation to Interferon Sensitivity. The Journal of Infectious Diseases. 185(5). 573–583. 22 indexed citations

20.

François, Catherine, Gilles Duverlie, Dominique Rebouillat, et al.. (2000). Expression of Hepatitis C Virus Proteins Interferes with the Antiviral Action of Interferon Independently of PKR-Mediated Control of Protein Synthesis. Journal of Virology. 74(12). 5587–5596. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact